Pasithea Therapeutics (KTTA) Assets (2021 - 2024)
Historic Assets for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $18.6 million.
- Pasithea Therapeutics' Assets fell 3920.74% to $18.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $18.6 million, marking a year-over-year decrease of 3920.74%. This contributed to the annual value of $26.1 million for FY2023, which is 4219.39% down from last year.
- As of Q3 2024, Pasithea Therapeutics' Assets stood at $18.6 million, which was down 3920.74% from $17.7 million recorded in Q2 2024.
- Over the past 5 years, Pasithea Therapeutics' Assets peaked at $53.3 million during Q4 2021, and registered a low of $17.7 million during Q2 2024.
- Moreover, its 4-year median value for Assets was $38.1 million (2023), whereas its average is $36.1 million.
- As far as peak fluctuations go, Pasithea Therapeutics' Assets skyrocketed by 13575.38% in 2022, and later crashed by 5369.94% in 2024.
- Over the past 4 years, Pasithea Therapeutics' Assets (Quarter) stood at $53.3 million in 2021, then decreased by 15.27% to $45.2 million in 2022, then plummeted by 42.19% to $26.1 million in 2023, then fell by 28.64% to $18.6 million in 2024.
- Its last three reported values are $18.6 million in Q3 2024, $17.7 million for Q2 2024, and $22.4 million during Q1 2024.